Actuate Therapeutics announced new positive data from its ongoing and fully enrolled randomized Phase 2 trial of elraglusib in...
Read moreGuRu Wireless, Inc., the leading provider of adaptive, long-range wireless energy transfer solutions, announces it has created an Advisory...
Read moreDefence prime Babcock Australasia has signed a Memorandum of Understanding with US-based autonomous aircraft pioneer PteroDynamics Inc to explore...
Read moreActuate Therapeutics, Inc. (NASDAQ: ACTU) announced that the Company will be added to the Russell 2000® Index as part...
Read moreGodrej Agrovet Limited, a leading agribusiness company in India, has entered into a strategic partnership with US-based Provivi to...
Read moreThe Department of Defense today announced the conclusion of the Hypersonic Accelerated Manufactured Prototype Demonstration (Hyper-AMPD!) prize challenge with...
Read moreActuate Therapeutics, Inc. has received Rare Pediatric Disease Designation from the FDA for elraglusib, a novel GSK-3β inhibitor being...
Read moreTransient Plasma Systems is featured in a recent article highlighting their groundbreaking work in plasma ignition technology, which offers...
Read moreNeuro-Bio’s CEO, Baroness Susan Greenfield, will lead the inaugural session at the upcoming WeMind International Forum in Barcelona. Susan...
Read morePteroDynamics Inc., an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, and Cornes Technologies Limited, a leading specialist importer and...
Read more